These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1906840)

  • 1. Protection of mice from lethal endotoxemia by use of an ornithine-containing lipid or a serine-containing lipid.
    Kawai Y; Kaneda K; Morisawa Y; Akagawa K
    Infect Immun; 1991 Aug; 59(8):2560-6. PubMed ID: 1906840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-lymphocyte mitogenicity and adjuvanticity of an ornithine-containing lipid or a serine-containing lipid.
    Kawai Y; Kamoshita K; Akagawa K
    FEMS Microbiol Lett; 1991 Oct; 67(2):127-9. PubMed ID: 1778427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation by an ornithine-containing lipid or a serine-containing lipid.
    Kawai Y; Akagawa K
    Infect Immun; 1989 Jul; 57(7):2086-91. PubMed ID: 2499544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothermic response of mice to ornithine-containing lipids and to endotoxin.
    Kawai Y; Takasuka N; Akagawa K; Naito S
    Infect Immun; 1996 Jun; 64(6):2101-5. PubMed ID: 8675313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoamino acids which are similar to bacterial endotoxin in both structure and biological activity related to physiological function.
    Kawai Y; Akagawa K; Yano I
    Adv Exp Med Biol; 1990; 256():159-62. PubMed ID: 2109501
    [No Abstract]   [Full Text] [Related]  

  • 6. Various kinds of lipoamino acids including a novel serine-containing lipid in an opportunistic pathogen Flavobacterium. Their structures and biological activities on erythrocytes.
    Kawai Y; Yano I; Kaneda K
    Eur J Biochem; 1988 Jan; 171(1-2):73-80. PubMed ID: 3123236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
    Gérard C; Bruyns C; Marchant A; Abramowicz D; Vandenabeele P; Delvaux A; Fiers W; Goldman M; Velu T
    J Exp Med; 1993 Feb; 177(2):547-50. PubMed ID: 8426124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
    Lam C; Schütze E; Walzl H; Basalka E
    Circ Shock; 1987; 22(4):311-21. PubMed ID: 2820606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
    J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of wogonin on endotoxin-induced lethal shock in D-galactosamine-sensitized mice.
    Van Dien M; Takahashi K; Mu MM; Koide N; Sugiyama T; Mori I; Yoshida T; Yokochi T
    Microbiol Immunol; 2001; 45(11):751-6. PubMed ID: 11791668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.
    Seiler N
    Curr Drug Targets; 2000 Sep; 1(2):119-53. PubMed ID: 11465067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoids protect mice from two types of lethal shock induced by endotoxin.
    Takahashi K; Morikawa A; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T
    FEMS Immunol Med Microbiol; 2001 Jul; 31(1):29-33. PubMed ID: 11476978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells.
    Sakaguchi S; Furusawa S; Wu J; Nagata K
    Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ornithine-containing lipids stimulate CD14-dependent TNF-alpha production from murine macrophage-like J774.1 and RAW 264.7 cells.
    Kawai Y; Takasuka N; Inoue K; Akagawa K; Nishijima M
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):197-203. PubMed ID: 10865171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of chemotaxis, O(2)(-) production and myeloperoxidase release from human polymorphonuclear leukocytes by the ornithine-containing lipid and the serineglycine-containing lipid of Flavobacterium.
    Kawai Y; Okawarab AI; Okuyama H; Kura F; Suzuki K
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):205-9. PubMed ID: 10865172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monophosphoryl lipid A as a prophylactic for sepsis and septic shock.
    Gustafson GL; Rhodes MJ; Hegel T
    Prog Clin Biol Res; 1995; 392():567-79. PubMed ID: 8524964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (sho-saiko-to) in recombinant human tumor necrosis factor administered mice.
    Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y
    Biol Pharm Bull; 1996 Nov; 19(11):1474-8. PubMed ID: 8951167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.